Masimo Corp
General ticker "MASI" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $9.2B
Masimo Corp follows the US Stock Market performance with the rate: 38.3%.
Estimated limits based on current volatility of 1.6%: low 165.82$, high 171.14$
Factors to consider:
- US accounted for 51.7% of revenue in the fiscal year ended 2023-12-30
- Current price 18.7% above estimated high
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-30 to 2025-12-29
- 2023-12-30 to 2024-12-29 estimated range: [88.84$, 144.06$]
- 2024-12-29 to 2025-12-29 estimated range: [81.25$, 135.00$]
Financial Metrics affecting the MASI estimates:
- Negative: Operating cash flow per share per price, % of 1.68 <= 2.35
- Positive: Non-GAAP EPS, $ of 3.37 > 2.29
- Positive: -0.25 < Return on assets ratio (scaled to [-100,100]) of 2.61
- Positive: 1.03 < Operating profit margin, % of 6.72
- Negative: Industry operating cash flow per share per price (median), % of -5.15 <= 3.85
- Negative: Interest expense per share, $ of 0.95 > 0.74
Short-term MASI quotes
Long-term MASI plot with estimates
Financial data
| YTD | 2022-01-01 | 2022-12-31 | 2023-12-30 |
|---|---|---|---|
| Operating Revenue | $1,239.20MM | $2,035.80MM | $2,030.30MM |
| Operating Expenses | $963.40MM | $1,825.80MM | $1,893.80MM |
| Operating Income | $275.80MM | $210.00MM | $136.50MM |
| Non-Operating Income | $-1.40MM | $-16.60MM | $-48.40MM |
| Interest Expense | $0.35MM | $25.70MM | $50.30MM |
| R&D Expense | $137.23MM | $191.40MM | $175.20MM |
| Income(Loss) | $274.40MM | $193.40MM | $88.10MM |
| Taxes | $44.80MM | $49.90MM | $6.60MM |
| Profit(Loss) | $229.60MM | $143.50MM | $81.50MM |
| Stockholders Equity | $1,550.20MM | $1,338.90MM | $1,364.80MM |
| Inventory | $201.37MM | $501.00MM | $545.00MM |
| Assets | $1,887.00MM | $3,210.60MM | $3,041.50MM |
| Operating Cash Flow | $264.75MM | $29.50MM | $94.10MM |
| Capital expenditure | $34.93MM | $56.30MM | $44.00MM |
| Investing Cash Flow | $-37.53MM | $-1,057.60MM | $-81.20MM |
| Financing Cash Flow | $-122.40MM | $520.30MM | $-57.10MM |
| Earnings Per Share* | $4.16 | $2.68 | $1.54 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.